References
- Atsumi K, Shioyama Y, Nakamura K, et al (2010). Predictive factors of esophageal stenosis associated with tumor regression in radiation therapy for locally advanced esophageal cancer. J Radiat Res, 51, 9-14. https://doi.org/10.1269/jrr.09073
- Bao S, Wu Q, McLendon RE, et al (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444, 756-60. https://doi.org/10.1038/nature05236
- Brunner T B, Rupp A, Melzner W, et al (2008). Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost. Strahlenther Onkol, 184, 15-22. https://doi.org/10.1007/s00066-008-1787-5
- Cooper JS, Guo MD, Herskovic A, et al (1999). Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA, 281, 1623-7. https://doi.org/10.1001/jama.281.17.1623
- Gaspar LE, Winter K, Kocha WI, et al (2000). A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report. Cancer, 88, 988-95. https://doi.org/10.1002/(SICI)1097-0142(20000301)88:5<988::AID-CNCR7>3.0.CO;2-U
- Greene FL, Compton C, Fritz A, et al (2006). Esophagus., AJCC Cancer Staging Atlas. Springer Science+Business Media Inc, Chicago, pp. 77-88.
- Halperin EC, Perez CA, Brady LW, et al (2008). Biologic Basis of Radiation Therapy. In: McBride W.H. and Withers H.R. (eds.), Perez and Brady's principles and practice of radiation oncology. Lippincott Williams & Wilkins, Lippincott Williams & Wilkins, pp. 77-109.
- Hama Y, Uematsu M, Shioda A, et al (2002). Severe complications after hypofractionated high dose rate intracavitary brachytherapy following external beam irradiation for oesophageal carcinoma. Br J Radiol, 75, 238-42. https://doi.org/10.1259/bjr.75.891.750238
- Harney J, Goodchild K, Phillips H, et al (2003). A phase I/II study of CHARTWEL with concurrent chemotherapy in locally advanced, inoperable carcinoma of the oesophagus. Clin Oncol (R Coll Radiol), 15, 109-14. https://doi.org/10.1053/clon.2003.0200
- Hermann PC, Huber SL, Herrler T, et al (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 1, 313-23. https://doi.org/10.1016/j.stem.2007.06.002
- Kassam Z, Wong RK, Ringash J, et al (2008). A phase I/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagus. Clin Oncol (R Coll Radiol), 20, 53-60. https://doi.org/10.1016/j.clon.2007.10.003
- Kawaguchi Y, Nishiyama K, Miyagi K, et al (2011). Patterns of failure associated with involved field radiotherapy in patients with clinical stage I thoracic esophageal cancer. Jpn J Clin Oncol, 41, 1007-12. https://doi.org/10.1093/jjco/hyr069
- Khurana R, Dimri K, Lal P, et al (2007). Factors influencing the development of ulcers and strictures in carcinoma of the esophagus treated with radiotherapy with or without concurrent chemotherapy. J Cancer Res Ther, 3, 2-7. https://doi.org/10.4103/0973-1482.31963
- Lee Y, Auh SL, Wang Y, et al (2009). Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood, 114, 589-95. https://doi.org/10.1182/blood-2009-02-206870
- Minsky BD, Pajak TF, Ginsberg RJ, et al (2002). INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: highdose versus standard-dose radiation therapy. J Clin Oncol, 20, 1167-74. https://doi.org/10.1200/JCO.20.5.1167
- Nguyen GH, Murph MM, Chang J Y (2011). Cancer Stem Cell Radioresistance and Enrichment: Where Frontline Radiation Therapy May Fail in Lung and Esophageal Cancers. Cancers (Basel), 3, 1232-52. https://doi.org/10.3390/cancers3011232
- Seung SK, Smith JW, 2nd, Ross HJ (2008). Selective dose escalation of chemoradiotherapy for locally advanced esophageal cancer. Dis Esophagus, 21, 589-95. https://doi.org/10.1111/j.1442-2050.2008.00822.x
- Song YP, Ma JB, Hu LK, et al (2011). Phase I/II study of hypofractioned radiation with three-dimensional conformal radiotherapy for clinical T3-4N0-1M0 stage esophageal carcinoma. Technol Cancer Res Treat, 10, 25-30. https://doi.org/10.7785/tcrt.2012.500176
- Sykes A J, Burt P A, Slevin N J, et al (1998). Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery. Radiother Oncol, 48, 15-21. https://doi.org/10.1016/S0167-8140(98)00037-1
- Trotti A, Colevas AD, Setser A, et al (2003). CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol, 13, 176-81. https://doi.org/10.1016/S1053-4296(03)00031-6
- Vogelius IS, Westerly DC, Cannon GM, Bentzen SM (2010). Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques. Acta Oncol, 49, 1052-7. https://doi.org/10.3109/0284186X.2010.498835
- Vuong T, Szego P, David M, et al (2005). The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy. Int J Radiat Oncol Biol Phys, 63, 758-64. https://doi.org/10.1016/j.ijrobp.2005.02.042
- Zhao KL, Ma JB, Liu G, et al (2010). Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary? Int J Radiat Oncol Biol Phys, 76, 446-51. https://doi.org/10.1016/j.ijrobp.2009.02.078
Cited by
- High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma vol.95, pp.33, 2016, https://doi.org/10.1097/MD.0000000000004591